EuroEyes International Eye Clinic Limited

HKEX:1846.HK

4.65 (HKD) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q1
Revenue 367.907183.954346.382173.191294.665147.333315.626157.813313.253156.627319.678159.839284.985142.493188.83394.417111.759111.759104.86101.31599.634
Cost of Revenue 211.61899.984185.8789.4173.21383.188180.22986.536166.59580.267166.91579.927146.50573.253113.21356.60768.99268.99261.10355.60458.509
Gross Profit 156.28983.97160.51283.791121.45264.145135.39771.277146.65876.36152.76379.913138.4869.2475.6237.8142.76742.76743.75645.71241.126
Gross Profit Ratio 0.4250.4560.4630.4840.4120.4350.4290.4520.4680.4880.4780.50.4860.4860.40.40.3830.3830.4170.4510.413
Reseach & Development Expenses 000000000000000000000
General & Administrative Expenses 25.39925.39919.25319.25318.17818.17820.49720.49715.67915.67918.8118.8117.04417.04413.20213.20222.93522.9359.4718.5142.294
Selling & Marketing Expenses 19.15819.15817.30117.30113.76413.76414.56714.56713.52713.52713.35713.35711.87711.87711.14511.14517.31817.31814.35911.21411.092
SG&A 77.46444.63866.03736.58360.00131.95960.84735.06352.34929.26157.27232.16757.84128.9348.69424.35240.25340.25323.82929.72813.386
Other Expenses 0000000000000000006.1145.062.158
Operating Expenses 77.46438.33766.03738.93360.00133.53860.84734.40552.34924.66557.27230.09557.84131.53448.69423.94941.93341.93329.94234.78915.544
Operating Income 78.82541.74294.47547.22961.45133.53174.5536.84394.30947.85595.49147.92380.63941.53426.92613.5713.60613.60613.60210.98524.933
Operating Income Ratio 0.2140.2270.2730.2730.2090.2280.2360.2330.3010.3060.2990.30.2830.2910.1430.1440.1220.1220.130.1080.25
Total Other Income Expenses Net 19.1817.262-1.871-0.927-2.737-4.174-4.284-1.715.3871.9930.4860.066-8.113-5.271-0.804-0.509-13.381-13.381-3.061-0.652-1.626
Income Before Tax 98.00649.00392.60446.30258.71429.35770.26635.13399.69649.84895.97747.98972.52636.26326.12213.0610.2250.22510.54110.33323.307
Income Before Tax Ratio 0.2660.2660.2670.2670.1990.1990.2230.2230.3180.3180.30.30.2540.2540.1380.1380.0020.0020.1010.1020.234
Income Tax Expense 32.86316.43224.49312.24718.6639.33226.79913.432.8916.44530.39915.225.13212.5669.4434.7224.7484.7488.1017.41410.124
Net Income 63.76631.88367.47633.73842.94421.47246.52823.26468.42234.21165.13832.56947.41323.70718.1679.084-4.311-4.3112.2642.91813.183
Net Income Ratio 0.1730.1730.1950.1950.1460.1460.1470.1470.2180.2180.2040.2040.1660.1660.0960.096-0.039-0.0390.0220.0290.132
EPS 0.190.0960.20.10.130.0650.140.070.210.10.20.0990.140.0560.0550.028-0.016-0.0160.0070.0090.042
EPS Diluted 0.190.0960.20.10.130.0650.140.070.210.10.20.0990.120.0560.0550.028-0.016-0.0160.0070.0090.042
EBITDA 124.45351.359136.19756.199100.3641.543116.36445.727132.07655.02132.38255.018115.24747.92959.65219.60919.08319.08313.47928.31840.419
EBITDA Ratio 0.3380.2790.3930.3240.3410.2820.3690.290.4220.3510.4140.3440.4040.3360.3160.2080.1710.1710.1290.2790.406